Childbirth is a unique experience that affects maternal health physiologically, emotionally, and socially, and represents a crucial step in the transition to motherhood. Primiparous women often experience fear related to childbirth due to uncertainty about the process, pain, or possible complications. This randomized controlled trial aims to evaluate the effect of a QR code-based virtual tour of the delivery room on primiparous women's fear of childbirth, childbirth readiness, vaginal birth rate, and postpartum breastfeeding self-efficacy. Participants will be provided access to three virtual videos via QR codes, allowing them to explore the delivery room, understand the admission process, and learn about postpartum care. The study will assess outcomes using validated scales for childbirth fear, prenatal readiness, birth-related self-efficacy, and postpartum breastfeeding. By familiarizing participants with the delivery environment, this intervention aims to reduce fear, improve confidence and preparedness, and encourage vaginal delivery. The findings are expected to inform strategies to enhance maternal experiences, support national initiatives such as the Normal Birth Action Plan, and contribute to safer, more satisfying birth and breastfeeding outcomes.
Age range
18 Years – 45 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Wijma Birth Expectation/Experience Scale (W-Deq) Version A
Timeframe: It will be administered as a pre-test between the 28th and 32nd weeks of pregnancy, and as a post-test between the 38th and 40th weeks of pregnancy.
Prenatal Self-Assessment Scale-Readiness for Childbirth Subscale (PSAS-DHO)
Timeframe: It will be administered as a pre-test between the 28th and 32nd weeks of pregnancy, and as a post-test between the 38th and 40th weeks of pregnancy.
Self-Efficacy Scale for Normal Delivery
Timeframe: It will be administered as a pre-test between the 28th and 32nd weeks of pregnancy, and as a post-test between the 38th and 40th weeks of pregnancy.
Birth Beliefs Scale (BBS)
Timeframe: It will be administered as a pre-test between the 28th and 32nd weeks of pregnancy, and as a post-test between the 38th and 40th weeks of pregnancy.